INCY

Incyte Corporation News Headlines

$72.27
*  
0.66
0.92%
Get INCY Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading INCY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
BioMarin Files Vimizim MA in Brazil - Analyst Blog
7/5/2013 3:20:01 PM - Zacks.com


Incyte: Financial Projection And Stock Valuation
7/2/2013 9:17:00 AM - Seeking Alpha


3 Sources Of Revenue For Incyte
6/26/2013 11:58:00 AM - Seeking Alpha


How Much Should You Pay For Incyte?
6/25/2013 12:08:00 PM - Seeking Alpha


Positive Data on Novartis' Jakavi - Analyst Blog
6/18/2013 4:30:54 PM - Zacks.com


Positive Data on Incyte's Jakafi - Analyst Blog
6/18/2013 3:30:23 PM - Zacks.com


Positive Data on Incyte/LLY's Baricitinib - Analyst Blog
6/14/2013 11:30:47 AM - Zacks.com


Incyte's Jakafi Label Updated - Analyst Blog
6/13/2013 2:10:01 PM - Zacks.com


When It Comes To Biotech, Diversity Is Key
6/12/2013 7:51:00 AM - Seeking Alpha


Incyte Presents Positive Jakafi Data - Analyst Blog
6/5/2013 4:29:17 PM - Zacks.com


Incyte Reveals Data on Oncology Candidate - Analyst Blog
6/4/2013 3:28:57 PM - Zacks.com


After Hours Most Active for May 30, 2013 : FCX, HPQ, MSFT, DPZ, MRK, PFE, PXP, INTC, SIRI, QQQ, VMED, INCY
5/30/2013 3:44:32 PM - NASDAQ.com News


6 Superstars For Your Biotech Portfolio: John McCamant
5/10/2013 2:57:00 PM - Seeking Alpha


Alnylam Narrows Loss, Sales Fall - Analyst Blog
5/7/2013 8:25:01 AM - Zacks.com


Arena Pharma Narrows Loss - Analyst Blog
5/6/2013 10:21:53 AM - Zacks.com


Narrower-Than-Expected Loss at Incyte - Analyst Blog
5/3/2013 1:31:00 PM - Zacks.com


Optimer's Dificid Cleared Down Under - Analyst Blog
5/1/2013 5:28:01 PM - Zacks.com


BioMarin Widens Loss, Maintains View - Analyst Blog
4/29/2013 10:50:23 AM - Zacks.com


Mid-Day Market Update: Markets Trim Losses, Incyte Drops
3/18/2013 11:44:28 AM - Benzinga


Mid-Morning Market Update: Markets Tumble, Cynosure To Acquire Palomar
3/18/2013 9:29:14 AM - Benzinga


Incyte's Jakafi Is Likely A $1 Billion Drug
2/27/2013 3:36:00 PM - Seeking Alpha


Revenues Rise at Incyte - Analyst Blog
2/15/2013 10:00:01 AM - Zacks.com


National Research Corporation (NRCI) Ex-Dividend Date Scheduled for February 14, 2013
2/12/2013 9:00:05 AM - NASDAQ.com News


Update on Lilly's Tabalumab - Analyst Blog
2/11/2013 4:40:01 PM - Zacks.com


Incyte Pharmaceuticals Is Primed For A Run
2/5/2013 3:13:39 AM - SeekingAlpha